Vapotherm(R) Announces FDA 510(k) Clearance for the All Patient Circuit(TM), Enabling High Velocity Therapy for Neonatal to Adult Patients

Vapotherm, Inc., a developer and manufacturer of advanced respiratory technology, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its All Patient ...
The New England Journal of Medicine

Nasal High-Flow Therapy during Neonatal Endotracheal Intubation

Neonatal endotracheal intubation often involves more than one attempt, and oxygen desaturation is common. It is unclear whether nasal high-flow therapy, which extends the time to desaturation during ...
Medindia

Vapotherm® Announces FDA 510(k) Clearance for the All Patient Circuit™, Enabling High Velocity Therapy for Neonatal to Adult Patients

Vapotherm, Inc., a developer and manufacturer of advanced respiratory technology, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its All Patient ...